[
    [
        {
            "time": "",
            "original_text": "大健康投融资周报丨再鼎港股上市，强生65亿美元收购Momента",
            "features": {
                "keywords": [
                    "再鼎",
                    "港股上市",
                    "强生",
                    "65亿美元",
                    "收购",
                    "Momента",
                    "大健康",
                    "投融资"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "大健康投融资周报丨再鼎港股上市，强生65亿美元收购Momenta",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]